Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

1articles mentioning drugs

5drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Nivolumab-CT ×

Nivolumab-CT

This drug is selected. Its supporting articles are shown below.

Nivolumab-CT1

Articles mentioning Nivolumab-CT

1 articles · page 1 of 1

6ER-013 Indirect comparison of pembrolizumab plus enfortumab vedotin and nivolumab plus gemcitabine-cisplatin in urothelial carcinoma

ejhpharm · abstract · 2026-03-18 · 5 matching annotations

96.4%

Nivolumab-CT nivolumab gemcitabine-cisplatin pembrolizumab EV-Pembrolizumab enfortumab vedotin gemcitabine urothelial carcinoma European Medicines Agency UC

…0 (95% CI, 0.45-0.81; p=0.0009) between EV-Pembrolizumab versus Nivolumab-CT. According to the ATE guide, these treatments presented a degre…